| 000 | 01772 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517110605.0 | ||
| 264 | 0 | _c20170612 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1572-0241 | ||
| 024 | 7 |
_a10.1038/ajg.2016.306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBilliet, Thomas | |
| 245 | 0 | 0 |
_aA Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _cOct 2016 |
||
| 300 |
_a1438-1445 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdalimumab _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xblood |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aInfliximab _xblood |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMinisatellite Repeats |
| 650 | 0 | 4 |
_aPharmacogenomic Variants _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Fc _xgenetics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDreesen, Erwin | |
| 700 | 1 | _aCleynen, Isabelle | |
| 700 | 1 | _aWollants, Willem-Jan | |
| 700 | 1 | _aFerrante, Marc | |
| 700 | 1 | _aVan Assche, Gert | |
| 700 | 1 | _aGils, Ann | |
| 700 | 1 | _aVermeire, Severine | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 111 _gno. 10 _gp. 1438-1445 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2016.306 _zAvailable from publisher's website |
| 999 |
_c26287705 _d26287705 |
||